StoneX Group
IBIO icon

StoneX Group’s iBio IBIO Stock Holding History

StoneX Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22.5K Buy
+16,087
New +$22.2K ﹤0.01% 1734

Other funds holding IBIO

Noesis Capital Mangement
Noesis Capital Mangement Boca Raton, Florida $843M AUM 33.46% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

StoneX Group's IBIO Position: Q3 2026 in Review

StoneX Group opened a new position in iBio (IBIO) in Q3 2026: 16,087 shares worth $22.5K. The stake represents ﹤0.01% of the portfolio and ranks #1734 among its holdings.

7 funds tracked by Wall St. Rank hold IBIO as of Q3 2026.

  • StoneX Group held 16,087 shares of iBio worth $22.5K as of Q3 2026.
  • iBio was a new StoneX Group position in Q3 2026.
  • iBio made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1734 holding.
  • 7 funds tracked by Wall St. Rank held iBio as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.